U.S. probing two new blood clot cases after J&J’s COVID-19 vaccine

- ADVERTISEMENT -

(Reuters) – Two new cases of blood clots after administration of Johnson & Johnson’s single-dose COVID-19 vaccine are being investigated by federal health officials, the U.S. Centers for Disease Control and Prevention said on Tuesday.

One case was in a male and the other was in a female, both of whom were below 60 years, according to the agency, taking the total number of confirmed such cases to 17 out of 8 million shots given.

The new cases come after U.S. health regulators on Friday recommended resumption of use of J&J’s shot, ending a 10-day pause to investigate its link to extremely rare but potentially deadly blood clots.

- ADVERTISEMENT -

The CDC and the Food and Drug Administration said on Friday the risks of experiencing the syndrome involving severe blood clots and low platelets as a result of the vaccine were very low.

(Reporting by Ankur Banerjee and Manojna Maddipatla in Bengaluru; Editing by Shailesh Kuber)

Related posts:

Little concern about J&J vaccine nationwide A mysterious blood-clotting complication is killing coronavirus patients FDA, CDC call for pause in use of Johnson & Johnson vaccine after six reported cases of rare blood clots Global race for a coronavirus vaccine could lead to this generation’s Sputnik moment